Founded in 2017 with headquarters in Taichung Science Park, Taiwan, and a US subsidiary (Surglasses, LLC) in California, Taiwan Main Orthopedics Biotech Co., Ltd. (Surglasses) is led by founder Dr. Wang. The company is committed to seamlessly integrating augmented reality (AR) and cutting-edge digital imaging into clinical surgery and medical education, delivering high-precision and cost-effective smart healthcare solutions worldwide.
In the medical device segment, the flagship Caduceus S Spine AR Surgical Navigation System projects 3D navigation guidance directly into the surgeon’s direct field of view. The system requires only a single C-arm imaging device to achieve precise localization without additional pre-operative or intra-operative CT scans, thereby significantly reducing radiation exposure for both patients and surgical teams. Delivering an ultra-high positioning precision of less than 2 millimeters (<2mm), it assists in minimally invasive spine surgeries, effectively reducing procedure duration and blood loss. Furthermore, the product lineup includes Foresee-X AR Smart Glasses and the OOOPDS Surgical Simulation Planning System, comprehensively addressing needs from pre-operative planning to intra-operative guidance.
In digital medical education, Surglasses offers the Asclepius Virtual Dissection Table and the AI voice-assisted Asclepius AI Table. Equipped with high-resolution 3D digital human anatomy models, CTRender volume rendering, radiological images, and pathological atlases, these platforms provide medical schools and simulation centers with an interactive alternative to traditional cadavers. Currently adopted by leading universities and medical schools across more than 100 countries, the system is proven to dramatically enhance student engagement and anatomical comprehension.
Regarding international regulatory compliance, Caduceus S has officially received US FDA 510(k) clearance, Taiwan TFDA Class II Medical Device Certification (Ministry Health Welfare Med. Device No. 008401), and Thailand FDA clearance, strictly adhering to global medical standards.
Frequently Asked Questions (Q&A)
Q: What are the core clinical advantages of Surglasses’ AR surgical navigation system?
A: The Caduceus S system overlays navigation graphics directly onto the surgeon's visual field, delivering positioning accuracy under 2mm. By relying on standard C-arm imaging, it significantly reduces intra-operative X-ray radiation exposure while enhancing the efficiency and safety of minimally invasive spine procedures.
Q: How does the Asclepius Virtual Dissection Table improve medical school education?
A: Asclepius enables students to intuitively explore human anatomy through multi-scale 3D digital models, pathological atlases, and AI interactive features. It addresses the scarcity of physical cadavers, with research showing it increases student comprehension and classroom participation by over 90%.
Q: Which international regulatory clearances have Surglasses products achieved?
A: Surglasses’ Caduceus S spine navigation system has received US FDA 510(k) clearance, Taiwan TFDA Class II medical device certification, and Thailand FDA approval, establishing complete regulatory qualifications for global market entry.
Contact Information
To schedule a live product demonstration, request equipment quotes, or discuss global distribution and partnership opportunities, please reach out to our representatives :
Taiwan Headquarters (Taichung Science Park): +886 4 2565 2818 [1]US Subsidiary (Rancho Cucamonga, CA): Toll-Free +1 (888) 836-7198 [1]Official Email: info@surglasses.com
